Live Breaking News & Updates on Autolus Therapeutics Plc|Page 3
Stay updated with breaking news from Autolus therapeutics plc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) and Autolus Therapeutics (NASDAQ:AUTL – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, institutional ownership, profitability, valuation and earnings. Analyst Ratings This is a breakdown of recent recommendations […] ....
Autolus Therapeutics plc (NASDAQ:AUTL – Get Rating) saw a significant decrease in short interest in May. As of May 15th, there was short interest totalling 739,700 shares, a decrease of 14.1% from the April 30th total of 861,000 shares. Based on an average daily trading volume, of 573,600 shares, the days-to-cover ratio is currently 1.3 […] ....
Autolus Therapeutics plc (NASDAQ:AUTL – Get Rating) shares saw strong trading volume on Wednesday . 610,756 shares were traded during mid-day trading, an increase of 2% from the previous session’s volume of 600,028 shares.The stock last traded at $2.90 and had previously closed at $3.19. Analysts Set New Price Targets Several analysts have recently commented […] ....
Autolus Therapeutics (NASDAQ:AUTL – Get Rating) and Seagen (NASDAQ:SGEN – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, earnings, institutional ownership and profitability. Insider and Institutional Ownership 70.1% of Autolus Therapeutics shares are owned […] ....
Seagen (NASDAQ:SGEN – Get Rating) and Autolus Therapeutics (NASDAQ:AUTL – Get Rating) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends. Institutional & Insider Ownership 86.3% of Seagen shares are held by […] ....